Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy

Table 3 Analysis of melanoma recurrence according to MMP-23 expression in the entire cohort and the subset of patients who received immunotherapy after primary resection

	MMP-23 composite score
	Entire cohort^a		Immunotherapy after primary resection^b
	0 - 2	3 - 4	0 - 2	3 - 4
Recurrence
Yes	11 (59%)	42 (81%)	5 (46%)	23 (79%)
No	8 (41%)	10 (19%)	6 (54%)	6 (21%)
Total	19 (100%)	52 (100%)	11 (100%)	29 (100%)

ISSN: 1479-5876